Correlation Between Pharma Bio and Covalon Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharma Bio and Covalon Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharma Bio and Covalon Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharma Bio Serv and Covalon Technologies, you can compare the effects of market volatilities on Pharma Bio and Covalon Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharma Bio with a short position of Covalon Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharma Bio and Covalon Technologies.

Diversification Opportunities for Pharma Bio and Covalon Technologies

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pharma and Covalon is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Pharma Bio Serv and Covalon Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Covalon Technologies and Pharma Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharma Bio Serv are associated (or correlated) with Covalon Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Covalon Technologies has no effect on the direction of Pharma Bio i.e., Pharma Bio and Covalon Technologies go up and down completely randomly.

Pair Corralation between Pharma Bio and Covalon Technologies

Given the investment horizon of 90 days Pharma Bio Serv is expected to generate 1.62 times more return on investment than Covalon Technologies. However, Pharma Bio is 1.62 times more volatile than Covalon Technologies. It trades about 0.08 of its potential returns per unit of risk. Covalon Technologies is currently generating about 0.0 per unit of risk. If you would invest  55.00  in Pharma Bio Serv on October 21, 2024 and sell it today you would earn a total of  3.00  from holding Pharma Bio Serv or generate 5.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pharma Bio Serv  vs.  Covalon Technologies

 Performance 
       Timeline  
Pharma Bio Serv 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pharma Bio Serv are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Pharma Bio may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Covalon Technologies 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Covalon Technologies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Covalon Technologies may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pharma Bio and Covalon Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharma Bio and Covalon Technologies

The main advantage of trading using opposite Pharma Bio and Covalon Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharma Bio position performs unexpectedly, Covalon Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Covalon Technologies will offset losses from the drop in Covalon Technologies' long position.
The idea behind Pharma Bio Serv and Covalon Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites